Vivos Therapeutics (VVOS) Other Non-Current Liabilities (2022 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other Non-Current Liabilities of $1.3 million for Q1 2026, little changed quarter-over-quarter from $1.3 million in Q4 2025.
Vivos Therapeutics (VVOS) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other Non-Current Liabilities for 4 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $1.3 million in Q1 2026 per VVOS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.2 million in Q2 2023 and bottomed at $101000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $1.2 million across 4 years, with a median of $1.3 million in 2023.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 1219.8% in 2023 and fell as far as 1219.8% in 2023.
- Vivos Therapeutics' Other Non-Current Liabilities stood at $101000.0 in 2022, then jumped by 494.06% to $600000.0 in 2023, then soared by 116.67% to $1.3 million in 2025, then changed by 0.0% to $1.3 million in 2026.
- Business Quant data shows VVOS's Other Non-Current Liabilities at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Mar 31, 2022 | 101,000.00 |